Projects funded by the NCN
Investigating the mechanisms of CD20 downregulation triggered by tyrosine kinase inhibitors in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia
2023/49/N/NZ5/04272
Keywords:
tyrosine kinase inhibitors acute lymphoblastic leukemia CD20 rituximab
Descriptors:
- NZ5_7: Human disease treatment
- NZ6_1: Adaptive and innate immunity
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 22 - announced on 2023-03-16
Amount awarded: 204 906 PLN
Project start date (Y-m-d): 2024-06-17
Project end date (Y-m-d): 2027-06-16
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.